Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use

An expression method and agonist technology, applied in the field of genetic engineering, can solve the problems of low synthesis efficiency and high cost, and achieve the effects of low cost, lower blood sugar and high efficiency

Inactive Publication Date: 2008-01-09
JINAN UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to overcome the problems of low synthesis efficiency and high cost in existing VPAC2 type receptor specific agonists, and provide a recombinant VPAC2 type receptor specific agonist RMBAY with high stability and high activity, which can pass gene Large-scale production of engineering methods improves production efficiency and reduces costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use
  • Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use
  • Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The preparation of embodiment 1 specific agonist RMBAY

[0030] The schematic diagram of the preparation of the specific agonist RMBAY is shown in Figure 1.

[0031] 1. Preparation of RMBAY gene

[0032] Chain extension reaction: Primer F2 (0.1OD / μl) 5μl, F3 (0.1OD / μl) 5μl, 10×TaKaRa LA Buffer 10μl, dNTP 16μl, H 2 O 63μl, 94°C, 10min; lower to 55°C, add TaKaRa LA Taq enzyme 1μl, keep warm for 5min; 72°C, 5min; the result is the extension reaction solution.

[0033] PCR reaction: primer F1 (0.01OD / μl) 1μl, F4 (0.01OD / μl) 1μl, extension reaction solution 1μl, dNTP 10μl, 10×TaKaRa Ex Buffer 10μl, TaKaRaEx Taq enzyme 1μl, H 2 O 76μl, 94°C, 4min; 94°C, 30sec, 55°C, 30sec, 72°C, 30sec, 32 cycles; 72°C, 10min.

[0034] F1: NNNNNN CAT ATG CAT AGC GAT GCG GTG TTT ACC GAA AAC TATACC AAA CTG CGT AAA CAG;

[0035] F2: CTG GCG GCG AAA AAA TAT CTG AAC GAT CTG AAA AAA GGC GGCACC;

[0036] F3: CGC CAG CTG TTT ACG CAG TTT GGT ATA GTT TTC GGT AAA CACCGC ATC GCT ATG CA;

[0037] F...

Embodiment 2

[0042] The receptor selectivity assay of embodiment 2RMBAY

[0043] Using Chinese hamster ovary cells (CHO cells) specifically expressing the three receptors of PACAP, 125 I-labeled ligand and receptor competition binding assay (Competitionbinding assay).

[0044] 1. Membrane protein preparation: collect CHO cells specifically expressing VPAC2 receptors and resuspend in 1mM NaHCO 3 , Immediately freeze in liquid nitrogen for 2-3 hours, take out and thaw, centrifuge at 400g for 10min at 4°C, take the supernatant at 4°C, centrifuge at 20,000 for 10min, and resuspend the pellet in 1mM NaHCO 3 ;, as a crude product of cell membrane protein.

[0045] 2. Take 10μg membrane protein prepared above, add 0.1nmol / 125 I-PACAP38 (1813.14Ci / mmol) and the recombinant polypeptide to be tested, and gradually increase the concentration of the polypeptide (10 -10 -10 -5 mol / L), the reaction was carried out in 100 μl buffer (20mmol / L HEPES, pH7.4, 150mmol / L NaCl, 0.5% BSA, 2mmol / L MgCl2, 0....

Embodiment 3

[0051] Example 3RMBAY promotes the activity measurement of VPAC2-CHO cell cAMP generation

[0052] Using the screened VPAC2-CHO cells highly expressing VAPC2 receptors, the activity of RMBAY in promoting intracellular cAMP synthesis was detected.

[0053] Scrape the VPAC2-CHO cells in the logarithmic growth phase, wash them twice with PBS, and adjust the concentration of the cell suspension to 1×10 6 Each / ml, add the same concentration of RMPACAP or RMBAY, adjust the concentration of the polypeptide from 10 -12 mol / L to 10 -6 mol / L; incubate at 37°C for 5 min, add 2 times the volume of 0.2 mol / L HCl to 100 μl of cell suspension, place at room temperature for 20 min, dissolve the cells by pipetting with a tip and mix well, centrifuge at 1000 g for 10 min, draw the supernatant and press Cyclic AMP Enzyme Immunoassay Kit instructions for measuring cAMP concentration.

[0054] Both RMBAY and RMPACAP can effectively stimulate the generation of intracellular cAMP, and the EC of R...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A recombinant VPAC2-type acceptor differential agonist RMBAY, its expression and use are disclosed. It can decrease blood sugar and be used for diseases diagnose and treatment related to VPAC2-type acceptor. It achieves low cost, high efficiency and stability.

Description

technical field [0001] The invention relates to the field of genetic engineering, in particular to a VPAC2 receptor-specific agonist and its expression method, and its application in the preparation of medicines for treating VPAC2 receptor-related diseases. Background technique [0002] Pituitary adenylate cyclase activating polypeptide (pituitary adenylate cyclase activating polypeptide, PACAP) was discovered in 1989. It is a neuropeptide with important biological functions secreted by the pituitary gland. It belongs to the secretin / glucagon / VIP family of new members. PACAP and its receptors (PAC1, VPAC1, and VPAC2) are widely distributed in the central nervous system, peripheral nervous system, and non-nervous tissues, such as brain, testis, ovary, respiratory tract, lung, and pancreas. It has been confirmed that PACAP has neurotransmitter / modulator, protects nerve cells; promotes hormone secretion, regulates endocrine balance; regulates gonad function and germ cell produ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/435C12N15/12C12N15/09A61K38/17A61P1/00A61P7/00A61P9/00A61P15/00A61P21/00A61P25/00A61P31/00
Inventor 洪岸余榕捷
Owner JINAN UNIVERSITY